Comparison of hepatic arterial infusion chemotherapyversussorafenib monotherapy in patients with advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Comparison of hepatic arterial infusion chemotherapyversussorafenib monotherapy in patients with advanced hepatocellular carcinoma

Published:2015-09 Issue:9 Volume:16 Page:505-512
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:Journal of Digestive Diseases

Author:

Kawaoka Tomokazu¹,Aikata Hiroshi¹,Hyogo Hideyuki¹,Morio Reona¹,Morio Kei¹,Hatooka Masahiro¹,Fukuhara Takayuki¹,Kobayashi Tomoki¹,Naeshiro Noriaki¹,Miyaki Daisuke¹,Hiramatsu Akira¹,Imamura Michio¹,Kawakami Yoshiiku¹,Takahashi Shoichi¹,Waki Koji²,Tsuji Keiji²,Kohno Hirotaka³,Kohno Hiroshi³,Moriya Takashi⁴,Chayama Kazuaki¹

Affiliation:

1. Department of Medicine and Molecular Science, Division of Frontier Medical Science; Hiroshima University; Hiroshima Japan

2. Hiroshima City Asa Hospital; Hiroshima Japan

3. Kure Medical Center; Hiroshima Japan

4. Chugoku Rousai Hospital; Hiroshima Japan

Publisher

Wiley

Subject

Gastroenterology

Reference19 articles.

1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009